SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-19-019188
Filing Date
2019-04-02
Accepted
2019-04-02 09:35:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-7406_1sc13g.htm SC 13G 62221
  Complete submission text file 0001104659-19-019188.txt   63493
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Subject) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87637 | Film No.: 19723035
SIC: 2834 Pharmaceutical Preparations

Mailing Address 41 S. HIGH STREET SUITE 3400 COLUMBUS OH 43215
Business Address
Garlikov Donald E (Filed by) CIK: 0001772133 (see all company filings)

Type: SC 13G